VCYT FY 2019 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$120M+30.8% YoY

Gross Profit

$84M69.7% margin

Operating Income

-$15M-12.6% margin

Net Income

-$13M-10.5% margin

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$6M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$275M

Total Liabilities

$36M

Stockholders' Equity

$239M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$120M	$92M	+30.8%
Gross Profit	$84M	$59M	+42.3%
Operating Income	-$15M	-$22M	+32.0%
Net Income	-$13M	-$23M	+45.2%